Treatment Resistant Cancers
Urinary Tract Calculi III: Medical Management
Urinary Bladder
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 20, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Y Neuzillet1, F Audenet2, Y Loriot3
1Service d'urologie, hôpital Foch, université Paris Saclay, Suresnes, France.
Updated recommendations for muscle-invasive bladder carcinoma (MIBC) management emphasize diagnosis, treatment, and surveillance. Key updates include neoadjuvant chemotherapy before cystectomy and immunotherapy for metastatic disease.
Area of Science:
Background:
Approach:
Key Points:
Conclusions: